145

"Non-toxic" investments may hit European insurers' capital base

While some European firms are still reeling from investments in "toxic" paper, concern is mounting about potential losses in more mainstream holdings, as Sarfraz Thind reports

144

Germany maps out route to Solvency II

The MaRisk VA circular raises the country's preparations for 2012 to a new level. One result: risk management will become more of a board concern. Report by Jessica Baylis

134

Capital erosion isn't a problem for insurers -- yet

The financial crisis hasn't dented re/insurers' capital too badly. Sources of capital remain to be tapped. But pray for a light hurricane season, says Helen Yates.

127

Re-rating the rating agencies

The global financial crisis has raised serious questions about the reliability of credit ratings. Helen Yates asks what this means for European insurers and for ratings under Solvency II.

105

Is the test of use too loose?

Internal models for Solvency II should be fully embedded in the business but official guidance on this is quite vague, says John Ferry

102

Time to get serious about the models

Only forty-seven months to Solvency II! For insurers taking the internal model route crucial decisions are needed now. Jessica Baylis reports.